Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunimi Maeda

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2005
[Systemic edema in kidney diseases]Kunimi Maeda, Yasuhiko Tomino
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 5, 2020
Reticulocyte hemoglobin contentChie Ogawa, Ken Tsuchiya, Kunimi Maeda
Plos One|September 17, 2020
High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational studyChie Ogawa, Ken Tsuchiya, Kunimi Maeda
International Journal of Molecular Sciences|February 11, 2023
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda
ISRN Nephrology|June 27, 2014
Usefulness of change in estimated glomerular filtration rate as a predicting factor of progression of chronic kidney diseaseKunimi Maeda, Chieko Hamada, Satoshi Horikoshi, et al.
International Journal of Molecular Sciences|October 1, 2020
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis PatientsChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Nutrients|January 8, 2023
Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational StudyChie Ogawa, Ken Tsuchiya, Mineko Kanemitsu, et al.
Contributions to Nephrology|May 8, 2018
Renal Anemia and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda, et al.
Plos One|June 18, 2021
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfaChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Blood Purification|April 4, 2019
Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal AnemiaChie Ogawa, Ken Tsuchiya, Kosaku Nitta, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2005
[Systemic edema in kidney diseases]Kunimi Maeda, Yasuhiko Tomino
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 5, 2020
Reticulocyte hemoglobin contentChie Ogawa, Ken Tsuchiya, Kunimi Maeda
Plos One|September 17, 2020
High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational studyChie Ogawa, Ken Tsuchiya, Kunimi Maeda
International Journal of Molecular Sciences|February 11, 2023
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda
ISRN Nephrology|June 27, 2014
Usefulness of change in estimated glomerular filtration rate as a predicting factor of progression of chronic kidney diseaseKunimi Maeda, Chieko Hamada, Satoshi Horikoshi, et al.
International Journal of Molecular Sciences|October 1, 2020
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis PatientsChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Nutrients|January 8, 2023
Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational StudyChie Ogawa, Ken Tsuchiya, Mineko Kanemitsu, et al.
Contributions to Nephrology|May 8, 2018
Renal Anemia and Iron MetabolismChie Ogawa, Ken Tsuchiya, Kunimi Maeda, et al.
Plos One|June 18, 2021
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfaChie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, et al.
Blood Purification|April 4, 2019
Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal AnemiaChie Ogawa, Ken Tsuchiya, Kosaku Nitta, et al.
Pageof 3